THIRD QUARTER FINANCIAL STATEMENT AND DIVIDEND ANNOUNCEMENT FOR THE PERIOD ENDED 31 DECEMBER 2003 PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)


FINANCIAL STATEMENT AND DIVIDEND ANNOUNCEMENT FOR THE SECOND QUARTER ENDED 30 JUNE 2015

PART I - INFORMATION REQUIRED FOR ANNOUNCEMENTS OF QUARTERLY (Q1, Q2 & Q3), HALF-YEAR AND FULL YEAR RESULTS

1(a) An income statement (for the group) together with a comparative statement for the corresponding period of the immediately preceding financial year.

1(a)(i) Unaudited Group Income Statement for the second quarter ended 30 June 2015.

GROUP

Second Quarter

Year-To-Date

GROUP

Q2 2015

S$'000

Q2 2014

S$'000

Increase/ (Decrease)

%

30/6/2015

S$'000

30/6/2014

S$'000

Increase/ (Decrease)

%

Revenue

Other items of income

Interest income

Other income

Items of expense

Financial expense

Purchases and changes in inventories of consumables and medical supplies Employee benefits expense Depreciation and amortisation

Rental expense

Other expenses

Share of results of associates Profit/ (Loss) before tax Income tax

Profit/ (Loss) for the period

Attributable to:

Owners of the Company Non-controlling interests Profit/ (Loss) for the period

12,683

26

415

(2) (2,113)

(8,083) (387) (2,254) (1,549)

109

13,657

30

1,720

- (2,473)

(7,802) (929) (2,112) (1,926)

394

(7)

(13) (76)

N.M. (15)

4 (58)

7 (20) (72)

(307) N.M. (312)

(246)

117 (312)

24,861

56

2,307

(2) (4,253)

(15,566) (779) (4,508) (2,967)

282

27,591

61

4,065

(8) (4,846)

(16,105) (1,810) (4,334) (3,743)

518

(10)

(7) (43)

(75) (12)

(3) (57)

4 (21) (46)

(141) N.M. (146)

(140)

125 (146)

Revenue

Other items of income

Interest income

Other income

Items of expense

Financial expense

Purchases and changes in inventories of consumables and medical supplies Employee benefits expense Depreciation and amortisation

Rental expense

Other expenses

Share of results of associates Profit/ (Loss) before tax Income tax

Profit/ (Loss) for the period

Attributable to:

Owners of the Company Non-controlling interests Profit/ (Loss) for the period

(1,155)

(28)

559

-

(7)

(13) (76)

N.M. (15)

4 (58)

7 (20) (72)

(307) N.M. (312)

(246)

117 (312)

(567)

(72)

1,389

-

(10)

(7) (43)

(75) (12)

(3) (57)

4 (21) (46)

(141) N.M. (146)

(140)

125 (146)

Revenue

Other items of income

Interest income

Other income

Items of expense

Financial expense

Purchases and changes in inventories of consumables and medical supplies Employee benefits expense Depreciation and amortisation

Rental expense

Other expenses

Share of results of associates Profit/ (Loss) before tax Income tax

Profit/ (Loss) for the period

Attributable to:

Owners of the Company Non-controlling interests Profit/ (Loss) for the period

(1,183)

559

(7)

(13) (76)

N.M. (15)

4 (58)

7 (20) (72)

(307) N.M. (312)

(246)

117 (312)

(639)

1,389

(10)

(7) (43)

(75) (12)

(3) (57)

4 (21) (46)

(141) N.M. (146)

(140)

125 (146)

Revenue

Other items of income

Interest income

Other income

Items of expense

Financial expense

Purchases and changes in inventories of consumables and medical supplies Employee benefits expense Depreciation and amortisation

Rental expense

Other expenses

Share of results of associates Profit/ (Loss) before tax Income tax

Profit/ (Loss) for the period

Attributable to:

Owners of the Company Non-controlling interests Profit/ (Loss) for the period

(1,233)

50

846 (287)

(7)

(13) (76)

N.M. (15)

4 (58)

7 (20) (72)

(307) N.M. (312)

(246)

117 (312)

(779)

140

1,945 (556)

(10)

(7) (43)

(75) (12)

(3) (57)

4 (21) (46)

(141) N.M. (146)

(140)

125 (146)

Revenue

Other items of income

Interest income

Other income

Items of expense

Financial expense

Purchases and changes in inventories of consumables and medical supplies Employee benefits expense Depreciation and amortisation

Rental expense

Other expenses

Share of results of associates Profit/ (Loss) before tax Income tax

Profit/ (Loss) for the period

Attributable to:

Owners of the Company Non-controlling interests Profit/ (Loss) for the period

(1,183)

559

(7)

(13) (76)

N.M. (15)

4 (58)

7 (20) (72)

(307) N.M. (312)

(246)

117 (312)

(639)

1,389

(10)

(7) (43)

(75) (12)

(3) (57)

4 (21) (46)

(141) N.M. (146)

(140)

125 (146)

NM: Not Meaningful

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 2 of 12

1(a) An income statement (for the group) together with a comparative statement for the
corresponding period of the immediately preceding financial year (Cont'd).

Statement of Comprehensive Expense

Second Quarter

Year to date

Statement of Comprehensive Expense

Q2 2015

S$'000

Q2 2014

S$'000

Increase/ (Decrease)

%

30/6/2015

S$'000

30/6/2014

S$'000

Increase/ (Decrease)

%

Profit/(Loss) for the period

Other comprehensive income/ (expense)

Translation differences relating to financial statements of foreign subsidiaries

Total comprehensive income/ (expense) for the period

Total comprehensive income/ (expense) attributable to:

Owners of the parent

Non-controlling interests

Total comprehensive income/ (expense) for the period

(1,183)

90

559

2,576

(312)

(96) (135)

(180) (88) (135)

(639)

122

1,389

2,721

(146)

(96) (113)

(128) (72) (113)

Profit/(Loss) for the period

Other comprehensive income/ (expense)

Translation differences relating to financial statements of foreign subsidiaries

Total comprehensive income/ (expense) for the period

Total comprehensive income/ (expense) attributable to:

Owners of the parent

Non-controlling interests

Total comprehensive income/ (expense) for the period

(1,093)

3,135

(312)

(96) (135)

(180) (88) (135)

(517)

4,110

(146)

(96) (113)

(128) (72) (113)

Profit/(Loss) for the period

Other comprehensive income/ (expense)

Translation differences relating to financial statements of foreign subsidiaries

Total comprehensive income/ (expense) for the period

Total comprehensive income/ (expense) attributable to:

Owners of the parent

Non-controlling interests

Total comprehensive income/ (expense) for the period

(1,289)

196

1,608

1,527

(312)

(96) (135)

(180) (88) (135)

(835)

318

2,973

1,137

(146)

(96) (113)

(128) (72) (113)

Profit/(Loss) for the period

Other comprehensive income/ (expense)

Translation differences relating to financial statements of foreign subsidiaries

Total comprehensive income/ (expense) for the period

Total comprehensive income/ (expense) attributable to:

Owners of the parent

Non-controlling interests

Total comprehensive income/ (expense) for the period

(1,093)

3,135

(312)

(96) (135)

(180) (88) (135)

(517)

4,110

(146)

(96) (113)

(128) (72) (113)

1(a)(ii)

GROUP

Second Quarter

Year-To-Date

GROUP

Q2 2015

Q2 2014

30/06/2015

30/06/2014

GROUP

S$'000

S$'000

S$'000

S$'000

Other income:

Other income

Financial expense:

Interest expense:

- Bank loans

- Obligations under finance leases

- Others

Total financial expense

Depreciation and amortisation:

Depreciation of property, plant and equipment

415

1,720

2,307

4,065

Other income:

Other income

Financial expense:

Interest expense:

- Bank loans

- Obligations under finance leases

- Others

Total financial expense

Depreciation and amortisation:

Depreciation of property, plant and equipment

415

1,720

2,307

4,065

Other income:

Other income

Financial expense:

Interest expense:

- Bank loans

- Obligations under finance leases

- Others

Total financial expense

Depreciation and amortisation:

Depreciation of property, plant and equipment

-

1

-

-

-

-

-

2

-

7

-

1

Other income:

Other income

Financial expense:

Interest expense:

- Bank loans

- Obligations under finance leases

- Others

Total financial expense

Depreciation and amortisation:

Depreciation of property, plant and equipment

1

-

2

8

Other income:

Other income

Financial expense:

Interest expense:

- Bank loans

- Obligations under finance leases

- Others

Total financial expense

Depreciation and amortisation:

Depreciation of property, plant and equipment

387

929

779

1,810

Other income:

Other income

Financial expense:

Interest expense:

- Bank loans

- Obligations under finance leases

- Others

Total financial expense

Depreciation and amortisation:

Depreciation of property, plant and equipment

387

929

779

1,810

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 3 of 12

1(a) An income statement (for the group) together with a comparative statement for the corresponding period of the immediately preceding financial year (Cont'd)

1(a)(iii) Additional disclosures

Second Quarter

Year-To-Date

Q2 2015

Q2 2014

Increase/ (Decrease)

30/06/2015

30/06/2014

Increase/ (Decrease)

S$'000

S$'000

%

S$'000

S$'000

%

Interest income

Interest expense

Gain/(Loss) on disposal of property, plant and equipment

Gain/(Loss) on disposal of subsidiary

(Provision for)/ Reversal of allowance for doubtful debts

Reversal of reinstatement cost Bad debts written off Depreciation and amortisation

Foreign exchange gain/(loss) (net)

26 (2)

14

-

(97)

184* (13) (387) (1)

30

-

1

1,621

(61)

- (118) (929) (3)

(13) N.M.

N.M. (100)

59

N.M. (89) (58) (66)

57 (2)

33

-

(203)

184* (68) (779)

-

61 (8)

(1)

1,621

(109)

- (119) (1,810)

(3)

(7) (75)

N.M. (100)

86

N.M. (43) (57)

100

N.M. Not meaningful

* The reversal of reinstatement costs relates to the proposed disposal of the imaging and day surgery businesses and the relinquishing of two floors at levels 7 and 12 Paragon to the buyers.

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 4 of 12

1(b)(i) A balance sheet (for the issuer and group), together with a comparative statement as at the end of the immediately preceding financial year.

Group

Company

30/06/2015

31/12/2014

30/06/2015

31/12/2014

S$'000

S$'000

S$'000

S$'000

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

1,172

7,188

885

1,170

2,737

6,703

679

1,245

62

15,173

279

-

120

10,341

200

-

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

10,415

3,354

11,364

3,566

15,514

-

10,661

-

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

13,769

14,930

15,514

10,661

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

-

1,447

-

3,318

470

-

1,531

-

4,266

1,163

3,936

474

-

1,054

-

3,936

659

-

1,698

-

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

5,235

6,960

5,464

6,293

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

19,004

21,890

20,978

16,954

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

12,072

3,234

225

110

12,486

3,197

254

411

16,227

491

-

110

14,013

434

-

405

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

15,641

3,621

16,348

4,133

16,828

-

14,852

-

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

19,262

20,481

16,828

14,852

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

29

485

29

870

-

-

257

-

-

317

-

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

514

899

257

317

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

19,776

21,380

17,085

15,169

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

62,615 (61,798) (589)

62,615 (60,254) (533)

62,615 (58,722)

-

62,615 (60,830)

-

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

228 (1,000)

1,828 (1,318)

3,893

-

1,785

-

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

(772)*

510

3,893

1,785

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

ASSETS Current assets: Cash and bank

Trade and other receivables

Other assets

Inventories

Assets of disposal group classified as held for sale

Non-current assets: Investments in subsidiaries Investments in associates Other investments

Property, plant and equipment

Other assets

TOTAL ASSETS

EQUITY AND LIABILITIES Current liabilities:

Trade and other payables

Other liabilities Income tax payable Provision

Liabilities directly associated with disposal group classified as held for sale

Non-current liabilities: Deferred tax liabilities Provisions

Other payables

TOTAL LIABILITIES

Equity attributable to owners of the company:

Share capital

Retained earnings

Foreign currency translation reserve

Non-controlling interests

TOTAL EQUITY *

TOTAL EQUITY AND LIABILITIES

19,004

21,890

20,978

16,954

*The disposal of the business and assets relating to Pacific Healthcare Imaging announced to SGXNET on 3 August 2015 will result in a gain on sale of S$1.98m and change the net asset value to a positive value of S$1,208,000.

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 5 of 12

1(b)(ii) Aggregate amount of group's borrowings and debt securities.

Not Applicable. PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 6 of 12

1(c) A cash flow statement (for the group), together with a comparative statement for the corresponding period of the immediately preceding financial year.

GROUP

Q2 2015

Q2 2014

GROUP

S$'000

S$'000

Cash flows from operating activities:

Profit (Loss) before tax Adjustments for: Depreciation expense Interest income

Interest expense

Fair value adjustment on financial assets and financial liabilities

Bad trade receivables written off

Goodwill impairment

(Reversal of)/Provision for doubtful debts Reversal of reinstatement cost Impairment loss on other investment Share of results of associates

Gain on disposal of property, plant and equipment

Fixed asset written off

Gain on disposal of subsidiary Loss on disposal of associate Realised exchange (gain)/loss, net Unrealised exchange (gain)/loss, net

Operating cash flows before changes in working capital

Trade and other receivables

Inventories

Trade and other payables Cash flows from operations Income tax refund/ (paid)

Net cash flows used in operating activities

Cash flow from investing activities: Disposal of subsidiary net of cash disposed Disposal of associates net of cash disposed Purchase of property, plant and equipment

Proceed from disposal of property, plant and equipment

Dividend income from associates

Investment in associates

Interest received

Net cash flows from (used in) investing activities

(1,155)

387 (26)

2 (1)

13

-

97 (184)

- (109) (14)

8

-

1

-

1

559

929 (30)

-

6

118

-

61

-

50 (394) (1)

10

(1,621)

- (1,077)

3

Cash flows from operating activities:

Profit (Loss) before tax Adjustments for: Depreciation expense Interest income

Interest expense

Fair value adjustment on financial assets and financial liabilities

Bad trade receivables written off

Goodwill impairment

(Reversal of)/Provision for doubtful debts Reversal of reinstatement cost Impairment loss on other investment Share of results of associates

Gain on disposal of property, plant and equipment

Fixed asset written off

Gain on disposal of subsidiary Loss on disposal of associate Realised exchange (gain)/loss, net Unrealised exchange (gain)/loss, net

Operating cash flows before changes in working capital

Trade and other receivables

Inventories

Trade and other payables Cash flows from operations Income tax refund/ (paid)

Net cash flows used in operating activities

Cash flow from investing activities: Disposal of subsidiary net of cash disposed Disposal of associates net of cash disposed Purchase of property, plant and equipment

Proceed from disposal of property, plant and equipment

Dividend income from associates

Investment in associates

Interest received

Net cash flows from (used in) investing activities

(980)

702 (59)

473

(1,387)

558

21 (614)

Cash flows from operating activities:

Profit (Loss) before tax Adjustments for: Depreciation expense Interest income

Interest expense

Fair value adjustment on financial assets and financial liabilities

Bad trade receivables written off

Goodwill impairment

(Reversal of)/Provision for doubtful debts Reversal of reinstatement cost Impairment loss on other investment Share of results of associates

Gain on disposal of property, plant and equipment

Fixed asset written off

Gain on disposal of subsidiary Loss on disposal of associate Realised exchange (gain)/loss, net Unrealised exchange (gain)/loss, net

Operating cash flows before changes in working capital

Trade and other receivables

Inventories

Trade and other payables Cash flows from operations Income tax refund/ (paid)

Net cash flows used in operating activities

Cash flow from investing activities: Disposal of subsidiary net of cash disposed Disposal of associates net of cash disposed Purchase of property, plant and equipment

Proceed from disposal of property, plant and equipment

Dividend income from associates

Investment in associates

Interest received

Net cash flows from (used in) investing activities

136

(141)

(1,422)

(45)

Cash flows from operating activities:

Profit (Loss) before tax Adjustments for: Depreciation expense Interest income

Interest expense

Fair value adjustment on financial assets and financial liabilities

Bad trade receivables written off

Goodwill impairment

(Reversal of)/Provision for doubtful debts Reversal of reinstatement cost Impairment loss on other investment Share of results of associates

Gain on disposal of property, plant and equipment

Fixed asset written off

Gain on disposal of subsidiary Loss on disposal of associate Realised exchange (gain)/loss, net Unrealised exchange (gain)/loss, net

Operating cash flows before changes in working capital

Trade and other receivables

Inventories

Trade and other payables Cash flows from operations Income tax refund/ (paid)

Net cash flows used in operating activities

Cash flow from investing activities: Disposal of subsidiary net of cash disposed Disposal of associates net of cash disposed Purchase of property, plant and equipment

Proceed from disposal of property, plant and equipment

Dividend income from associates

Investment in associates

Interest received

Net cash flows from (used in) investing activities

(5)

(1,467)

Cash flows from operating activities:

Profit (Loss) before tax Adjustments for: Depreciation expense Interest income

Interest expense

Fair value adjustment on financial assets and financial liabilities

Bad trade receivables written off

Goodwill impairment

(Reversal of)/Provision for doubtful debts Reversal of reinstatement cost Impairment loss on other investment Share of results of associates

Gain on disposal of property, plant and equipment

Fixed asset written off

Gain on disposal of subsidiary Loss on disposal of associate Realised exchange (gain)/loss, net Unrealised exchange (gain)/loss, net

Operating cash flows before changes in working capital

Trade and other receivables

Inventories

Trade and other payables Cash flows from operations Income tax refund/ (paid)

Net cash flows used in operating activities

Cash flow from investing activities: Disposal of subsidiary net of cash disposed Disposal of associates net of cash disposed Purchase of property, plant and equipment

Proceed from disposal of property, plant and equipment

Dividend income from associates

Investment in associates

Interest received

Net cash flows from (used in) investing activities

- (148) (67)

14

161

-

-

330

- (152)

1

170 (240)

-

Cash flows from operating activities:

Profit (Loss) before tax Adjustments for: Depreciation expense Interest income

Interest expense

Fair value adjustment on financial assets and financial liabilities

Bad trade receivables written off

Goodwill impairment

(Reversal of)/Provision for doubtful debts Reversal of reinstatement cost Impairment loss on other investment Share of results of associates

Gain on disposal of property, plant and equipment

Fixed asset written off

Gain on disposal of subsidiary Loss on disposal of associate Realised exchange (gain)/loss, net Unrealised exchange (gain)/loss, net

Operating cash flows before changes in working capital

Trade and other receivables

Inventories

Trade and other payables Cash flows from operations Income tax refund/ (paid)

Net cash flows used in operating activities

Cash flow from investing activities: Disposal of subsidiary net of cash disposed Disposal of associates net of cash disposed Purchase of property, plant and equipment

Proceed from disposal of property, plant and equipment

Dividend income from associates

Investment in associates

Interest received

Net cash flows from (used in) investing activities

(40)

109

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 7 of 12

GROUP

Q2 2015

Q2 2014

GROUP

S$'000

S$'000

Cash flow from financing activities:

Dividend paid

Repayment of obligation under finance leases

Capital contribution from non-controlling interests of subsidiary

Interest paid

Net cash flows from (used in) financing activities

Net decrease in cash and cash equivalents

Effect of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

(419) (14)

-

(2)

- (47)

13

-

Cash flow from financing activities:

Dividend paid

Repayment of obligation under finance leases

Capital contribution from non-controlling interests of subsidiary

Interest paid

Net cash flows from (used in) financing activities

Net decrease in cash and cash equivalents

Effect of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

(435)

(34)

Cash flow from financing activities:

Dividend paid

Repayment of obligation under finance leases

Capital contribution from non-controlling interests of subsidiary

Interest paid

Net cash flows from (used in) financing activities

Net decrease in cash and cash equivalents

Effect of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

(480) (1)

2,211

(1,392) (2)

3,500

Cash flow from financing activities:

Dividend paid

Repayment of obligation under finance leases

Capital contribution from non-controlling interests of subsidiary

Interest paid

Net cash flows from (used in) financing activities

Net decrease in cash and cash equivalents

Effect of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

1,730

2,106

Cash flow from financing activities:

Dividend paid

Repayment of obligation under finance leases

Capital contribution from non-controlling interests of subsidiary

Interest paid

Net cash flows from (used in) financing activities

Net decrease in cash and cash equivalents

Effect of exchange rate changes on cash and cash equivalents

Cash and cash equivalents at beginning of period

Cash and cash equivalents at end of period

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 8 of 12



1(d)(i) A statement (for the issuer and group) showing either (i) all changes in equity or (ii) changes in equity other than those arising from capitalisation issues and distributions to shareholders, together with a comparative statement for the corresponding period of the immediately preceding financial year.

GROUP

Attributable to owners of the parent

Non- controlling interests

GROUP

Other reserves

Non- controlling interests

GROUP

Equity, total

Share capital

Retained earnings

Other reserves, total

Foreign currency translation reserve

Fair value adjustment reserve

Reserve

of disposal group classified as held for sale

Premium paid on acquisition of non- controlling interests

Non- controlling interests

GROUP

Equity, total

Attributable to owners of the parent, total

Share capital

Retained earnings

Other reserves, total

Foreign currency translation reserve

Fair value adjustment reserve

Reserve

of disposal group classified as held for sale

Premium paid on acquisition of non- controlling interests

Non- controlling interests

S$'000

S$'000

S$'000

S$'000

S$'000

S$'000

S$'000

S$'000

S$'000

S$'000

Opening balance at 1 April

2015

Profit/ (loss) for the period Other comprehensive income/ (expense) for the period

742 (1,183)

90

1,938 (1,233)

(56)

62,615

-

-

(60,144) (1,233)

-

(533)

-

(56)

(203)

(2)

-

-

(283)

(54)

(47)

-

(1,196)

50

146

Total comprehensive income/ (expense) for the period

(1,093)

(1,289)

-

(1,233)

(56)

(2)

-

(54)

-

196

Dividend paid

(421)

(421)

-

(421)

-

-

-

-

-

-

Closing balance at 30 June

2015

(772)

228

62,615

(61,798)

(589)

(205)

-

(337)

(47)

(1,000)

Opening balance at 1 April

2014

Profit/ (loss) for the period Other comprehensive income/ (expense) for the period

1,441

559

2,576

5,188

846

762

62,615

-

-

(56,649)

846

-

(778)

762

(736)

767

5

(5)

(47)

-

(3,747) (287)

1,814

Total comprehensive income/

(expense) for the period

3,135

1,608

-

846

762

767

(5)

-

1,527

Closing balance at 30 June

2014

4,576

6,796

62,615

(55,803)

(16)

31

-

(47)

(2,220)

COMPANY

Equity,

Total

Share

Capital

Retained

earning

S$'000

S$'000

S$'000

Opening balance at 1 April 2015, as restated

Profit/ (loss) for the period

3,841

52

62,615

-

(58,774)

52

Total comprehensive income/ (expense) for the period

52

-

52

Closing balance at 30 June 2015

3,893

62,615

(58,722)

Opening balance at 1 April 2014, as restated

Profit/ (loss) for the period

6,493

4,587

62,615

-

(56,122)

4,587

Total comprehensive income/ (expense) for the period

4,587

-

4,587

Closing balance at 30 June 2014

11,080

62,615

(51,535)

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 9 of 12

1(d)(ii) Details of any changes in the company's share capital arising from rights issue, bonus issue, share buy-backs, exercise of share options or warrants, conversion of other issues of equity securities, issue of shares for cash or as consideration for acquisition or for any other purpose since the end of the previous period reported on. State also the number of shares that may be issued on conversion of all the outstanding
convertibles as well as the number of shares held as treasury shares, if any, against the total number of issued shares excluding treasury shares of the issuer, as at the end of the current financial period reported on and as at the end of the corresponding period
of the immediately preceding financial year.

2015

2014

Number of

Ordinary Shares

Share Capital

S$'000

Number of

Ordinary Shares

Share Capital

S$'000

As at 1 April

573,742,933

62,615

573,742,933

62,615

As at 30 June

573,742,933

62,615

573,742,933

62,615

At the end of the reporting period, there were no outstanding share options. The Company did not have any treasury shares as at 30 June 2015 and 30 June 2014.

1(d)(iii) To show the total number of issued shares excluding treasury shares as at the end of the current financial period and as at the end of the immediately preceding year.

30/06/2015

31/12/2014

Number of issued shares excluding treasury shares

573,742,933

573,742,933

1(d)(iv) A statement showing all sales, transfers, disposal, cancellation and/or use of treasury shares as at the end of the current financial period reported on.

There were no sales, transfers, disposal, cancellation and/or use of treasury shares as at 30 June 2015 (31 December 2014: Nil) as the Company did not have any treasury shares as at 30 June 2015 and 31 December 2014.

2. Whether the figures have been audited or reviewed and in accordance with which auditing standard or practice.

The financial statement on consolidated results for the second quarter ended 30 June 2015 have not been audited or reviewed.

3. Where the figures have been audited or reviewed, the auditors' report (including any
qualifications or emphasis of a matter). Not applicable.
4. Whether the same accounting policies and methods of computation as in the issuer's
most recently audited annual financial statements have been applied.

Accounting policies and methods of computation used in the consolidated financial statements for the second quarter ended 30 June 2015 are consistent with those applied in the financial statements for the year ended 31 December 2014. PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 10 of 12

5. If there are any changes in the accounting policies and methods of computation, including any required by an accounting standard, what has changed, as well as the reasons for, and the effect of, the change.

Not applicable.

6. Earnings per ordinary share of the group for the current financial period reported on and the corresponding period of the immediately preceding financial year, after deducting any provision for preference dividends.

Second Quarter

Year-To-Date

Q2 2015

Q2 2014

30/06/2015

30/06/2014

Loss/earnings per ordinary share of the group, after deducting any provision for preference dividends:

(i) Basic earnings per share

-0.21 cents

0.14 cents

-0.13 cents

0.34 cents

(ii) On a fully diluted basis

-0.21 cents

0.14 cents

-0.13 cents

0.34 cents

The basic and fully diluted loss/earnings per share for the quarter and half year ended 30 June 2015 were calculated based on the net loss attributable to owners of the parent company of S$1,235,000 (Q2 2014: earnings of $846,000) and S$780,000 (Year-To-Date 2014: earning of $1,945,000) divided by the weighted average number of ordinary shares 573,742,933 (Q2 2014: 573,742,933). The diluted earnings per share is the same as the basic earnings per share as there were no diluted common share equivalents outstanding during the relevant period.

7. Net asset value (for the issuer and group) per ordinary share based on the total number of issued shares excluding treasury shares of the issuer at the end of the:
(a) current financial period reported on; and
(b) immediately preceding financial year.

Group

Company

30/06/2015

31/12/2014

30/06/2015

31/12/2014

Net asset value per ordinary share

-0.13 cents *

0.08 cents

0.68 cents

0.31 cents

The net liability value per ordinary share of the Group has been calculated based on the shareholders' equity of S$772,000 (31 December 2014: asset of S$510,000) and the share capital of 573,742,933 ordinary shares (31 December 2014: 573,742,933 ordinary shares). The net asset value per ordinary share of the Company has been calculated based on the shareholders' equity of S$3,893,000 (31 December 2014: S$1,785,000) and the share capital of 573,742,933 ordinary shares (31 December 2011: 573,742,933 ordinary shares).

*The disposal of the business and assets relating to Pacific Healthcare Imaging announced to SGXNET on 3 August 2015 will result in a gain on sale of S$1.98m and change the net asset value per ordinary share to 0.21 cents.

PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 11 of 12

8. A review of the performance of the group, to the extent necessary for a
reasonable understanding of the group's business. It must include a discussion of the following:
(a) any significant factors that affected the turnover, costs, and earnings of the group for the current financial period reported on, including (where applicable) seasonal or cyclical factors; and
(b) any material factors that affected the cash flow, working capital, assets or liabilities
of the group during the current financial period reported on.

Revenue for the quarter ended 30 June 2015 ("Q2 2015") declined by 7% from S$13.7m to S$12.7m when compared to the corresponding period of last year ("Q2 2014"). The decline was on the back of a general decline in medical tourism, and specifically for patients from Indonesia and Russia. Total expenses fell by S$0.9m for Q2 2015 vs Q2 2014. Overall operating expenses were lower in Q2 2015, mainly due to the decrease in direct cost in line with the decrease in revenue and other expenses including bad debts. Depreciation expenses decreased by 58% from S$1.0m to S$0.4m with the completion of depreciation on heavy imaging equipment. For Q2 2015, the group incurred a loss attribute to the shareholders of S$1.2m as compare to profit of S$0.8m in Q2 2014. As at 30 June 2015, the Group's cash and bank balance decreased by S$1.5m to S$1.2m mainly due to decrease in revenue.

9. Where a forecast, or a prospect statement, has been previously disclosed to shareholders, any variance between it and the actual results.

The Group did not issue any forecast or a prospect statement.

10. A commentary at the date of the announcement of the significant trends and competitive conditions of the industry in which the group operates and any known factors or events that may affect the group in the next reporting period and the next 12 months.

The overall environment for the specialist medical business remains competitive, and the strong Singapore dollar has led to foreign patients seeking alternative service providers in the region e.g. Malaysia and Thailand. The nursing home business continues to be profitable and provides a stable source of revenue and cash flow. The current turnaround initiatives are on-going. In the second half of April 2015, the Group had ceased operations of its Indonesian business. On 3 August 2015, the Group announced the sale of its imaging business to Lifescan Imaging Pte Ltd. On 3 July 2015, trading in the Company's securities was suspended pending receipt and completion of an exit offer. PACIFIC HEALTHCARE HOLDINGS LTD.

(Co. Regn. No: 200100544H)

Page 12 of 12

11. Dividend
(a) Current Financial Period Reported On

Any interim (final) dividend declared (recommended) for the current financial period reported on? No

(b) Corresponding Period of the Immediately Preceding Financial Year

Any dividend declared for the corresponding period of the immediately preceding financial year? No

(c) Date payable

Not Applicable.

(d) Books closure date

Not Applicable.

12. If no dividend has been declared/recommended, a statement to that effect.

No dividend has been declared or recommended for the quarter ended 30 Jun 2015.

13. It the Group has obtained a general mandate from shareholders for IPTs , the aggregate value of such transactions as required under Rule 920(1) (a) (ii) . If no IPT mandate has been obtained, a statement to that effect.

The Group does not have a general mandate from shareholders for interested person transactions pursuant to Rule 920(1)(a)(ii)

14. Confirmation pursuant to Rule 705 (5) of the Listing Manual

The Board of Directors hereby confirms that, to the best of their knowledge, nothing has come to their attention which may render the unaudited financial statements of the Group and the Company for the period ended 30 June 2015 to be false or misleading in any material aspect.

BY ORDER OF THE BOARD

Wong Yee Kong (Andrew) Chief Executive Officer

12 August 2015

distributed by